Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Gülsen Kama is recorded as CFO at Bionano Genomics, Inc. (BNGO). Bionano Genomics, Inc. reported in an 8-K filed September 9, 2024 that Gülsen Kama was terminated as Chief Financial Officer, effective September 18, 2024. Bionano Genomics, Inc. reported in an 8-K filed August 14, 2023 that Gülsen Kama was appointed Chief Financial Officer, effective September 11, 2023. Gülsen Kama has spoken on 4 earnings calls across 1 company, most recently for Bionano Genomics, Inc. on August 7, 2024.
“In connection with the Reduction, the role of our Chief Financial Officer, Gülsen Kama, was impacted and Ms. Kama will no longer be employed with the Company effective September 18, 2024.”
“On August 14, 2023, the Company announced the appointment of Gülsen Kama as Bionano Genomics, Inc.'s (the "Company") Chief Financial Officer, effective as of September 11, 2023 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-09-11–present
2023-09-11–2024-09-18
Start not stated–2024-09-18
Recorded roles and call appearances connecting this person to public companies.
CFO
2023-09-11–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
